Standout Papers

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results ... 2003 2026 2010 2018 877
  1. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III (2005)
    Joseph P. McEvoy, Jonathan M. Meyer et al. Schizophrenia Research
  2. Regionally localized thinning of the cerebral cortex in schizophrenia (2003)
    Gina R. Kuperberg, Matthew R. Broome et al. Schizophrenia Research
  3. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19 (2021)
    Katlyn Nemani, Chenxiang Li et al. JAMA Psychiatry

Immediate Impact

4 by Nobel laureates 9 from Science/Nature 85 standout
Sub-graph 1 of 20

Citing Papers

Sleep Spindles: Mechanisms and Functions
2019 Standout
Channel opening and gating mechanism in AMPA-subtype glutamate receptors
2017 StandoutNatureNobel
50 intermediate papers

Works of Donald Goff being referenced

A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia
2007
A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia
2001
and 14 more

Author Peers

Author Last Decade Papers Cites
Donald Goff 9247 5427 2344 3392 284 19.6k
Gary Remington 11040 3003 1716 3328 466 17.3k
Stefan Borgwardt 7538 6588 3974 4537 349 23.1k
Hans‐Jürgen Möller 11543 3555 2889 2088 602 24.7k
Thomas B. Cooper 7475 3034 2029 5925 341 19.1k
Glenda MacQueen 6625 4260 2677 2654 268 18.9k
David C. Steffens 8961 4697 1838 1431 389 22.6k
Oliver Howes 11384 7285 5080 6595 425 26.3k
Kenneth L. Davis 7316 4704 1546 4196 281 20.2k
Stephen R. Marder 13823 3349 1602 2273 316 19.9k
Richard S.E. Keefe 19696 7265 2650 3133 343 28.1k

All Works

Loading papers...

Rankless by CCL
2026